Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 2, 2005
- Accepted February 25, 2005
- Published online March 1, 2005.
Copyright & Usage
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- 1Laboratory of Cellular Carcinogenesis and Tumor Promotion (LCCTP), Center for Cancer Research, National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD 20892-4255, U.S.A.
- 2National Cancer Center Hospital, 1-1 Tsukiji, 5-chome, Chuo-ku, Tokyo 104-0045, Japan
- Correspondence to: Unnur P. Thorgeirsson, Laboratory of Cellular Carcinogenesis and Tumor Promotion, Center for Cancer Research, National Cancer Institute, NIH, Bldg. 37, Room 4032A, Convent Drive, Bethesda, MD. 20892-4255, U.S.A. Tel: (301)-496-1982, Fax: (301)-496-8709, e-mail: thorgeiu{at}mail.nih.gov
Statistics from Altmetric.com
Cited By...
Jump to section
Related Articles
Cited By...
- The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research
- Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation
- Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines